D |
2019-12-17 |
|
Spark Therapeutics, Inc. |
4 |
D-Return |
--D |
25786.0000 |
0.0000 |
6 |
0001609351 |
Stock Option (Right to Buy) |
D |
2019-12-17 |
|
Spark Therapeutics, Inc. |
4 |
D-Return |
--D |
17203.0000 |
0.0000 |
5 |
0001609351 |
Stock Option (Right to Buy) |
D |
2019-12-17 |
|
Spark Therapeutics, Inc. |
4 |
D-Return |
--D |
6000.0000 |
0.0000 |
4 |
0001609351 |
Stock Option (Right to Buy) |
D |
2019-12-17 |
|
Spark Therapeutics, Inc. |
4 |
D-Return |
--D |
4000.0000 |
0.0000 |
3 |
0001609351 |
Stock Option (Right to Buy) |
D |
2019-12-17 |
|
Spark Therapeutics, Inc. |
4 |
D-Return |
--D |
4000.0000 |
0.0000 |
2 |
0001609351 |
Stock Option (Right to Buy) |
D |
2019-12-17 |
|
Spark Therapeutics, Inc. |
4 |
U-Tender |
--D |
14214.0000 |
0.0000 |
1 |
0001609351 |
Common Stock |
D |
2019-05-30 |
|
Spark Therapeutics, Inc. |
4 |
M-Exempt |
--D |
1500.0000 |
0.0000 |
2 |
0001609351 |
Restricted Stock Units |
A |
2019-05-30 |
|
Spark Therapeutics, Inc. |
4 |
M-Exempt |
--D |
1500.0000 |
14214.0000 |
1 |
0001609351 |
Common Stock |
D |
2018-05-31 |
|
Spark Therapeutics, Inc. |
4 |
M-Exempt |
--D |
1500.0000 |
0.0000 |
4 |
0001609351 |
Restricted Stock Units |
A |
2018-05-31 |
|
Spark Therapeutics, Inc. |
4 |
M-Exempt |
--D |
1500.0000 |
12714.0000 |
1 |
0001609351 |
Common Stock |
A |
2018-05-30 |
|
Spark Therapeutics, Inc. |
4 |
A-Award |
--D |
4000.0000 |
4000.0000 |
3 |
0001609351 |
Stock Option (right to buy) |
A |
2018-05-30 |
|
Spark Therapeutics, Inc. |
4 |
A-Award |
--D |
1500.0000 |
1500.0000 |
2 |
0001609351 |
Restricted Stock Units |
D |
2017-11-28 |
|
Spark Therapeutics, Inc. |
4 |
S-Sale |
--D |
29.0000 |
11214.0000 |
2 |
0001609351 |
Common Stock |
A |
2017-10-12 |
|
Spark Therapeutics, Inc. |
4 |
P-Purchase |
--D |
29.0000 |
11243.0000 |
1 |
0001609351 |
Common Stock |
D |
2017-06-15 |
|
Mead Johnson Nutrition Co |
4 |
D-Return |
--D |
1709.0000 |
0.0000 |
5 |
0001452575 |
Restricted Stock Units |
D |
2017-06-15 |
|
Mead Johnson Nutrition Co |
4 |
D-Return |
--I |
5180.0000 |
0.0000 |
4 |
0001452575 |
Common Stock |
D |
2017-06-15 |
|
Mead Johnson Nutrition Co |
4 |
D-Return |
--I |
5180.0000 |
0.0000 |
3 |
0001452575 |
Common Stock |
D |
2017-06-15 |
|
Mead Johnson Nutrition Co |
4 |
D-Return |
--I |
2590.0000 |
0.0000 |
2 |
0001452575 |
Common Stock |
D |
2017-06-15 |
|
Mead Johnson Nutrition Co |
4 |
D-Return |
--D |
13721.0000 |
0.0000 |
1 |
0001452575 |
Common Stock |
A |
2017-05-31 |
|
Spark Therapeutics, Inc. |
4 |
A-Award |
--D |
4000.0000 |
4000.0000 |
1 |
0001609351 |
Stock Option (right to buy) |
A |
2017-05-31 |
|
Spark Therapeutics, Inc. |
4 |
A-Award |
--D |
1500.0000 |
1500.0000 |
2 |
0001609351 |
Restricted Stock Units |
A |
2017-03-01 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
2373.0000 |
13721.0000 |
1 |
0001452575 |
Common Stock |
D |
2017-03-01 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
2373.0000 |
0.0000 |
6 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2017-02-28 |
|
Mead Johnson Nutrition Co |
4 |
A-Award |
--D |
1709.0000 |
1709.0000 |
5 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2016-06-01 |
|
Spark Therapeutics, Inc. |
4 |
A-Award |
--D |
6000.0000 |
6000.0000 |
1 |
0001609351 |
Stock Option (right to buy) |
A |
2016-02-29 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
2373.0000 |
2373.0000 |
6 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2016-02-26 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
1678.0000 |
11348.0000 |
1 |
0001452575 |
Common Stock |
D |
2016-02-26 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
1678.0000 |
0.0000 |
5 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2015-02-28 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
2146.0000 |
9670.0000 |
1 |
0001452575 |
Common Stock |
D |
2015-02-28 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
2146.0000 |
0.0000 |
5 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2015-02-26 |
|
Mead Johnson Nutrition Co |
4 |
A-Award |
--D |
1678.0000 |
1678.0000 |
1 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2015-02-04 |
|
Spark Therapeutics, Inc. |
4 |
C-Conversion |
--I |
31559.0000 |
31559.0000 |
1 |
0001609351 |
Common Stock |
A |
2015-02-04 |
|
Spark Therapeutics, Inc. |
4 |
P-Purchase |
--D |
5000.0000 |
11214.0000 |
2 |
0001609351 |
Common Stock |
A |
2015-02-04 |
|
Spark Therapeutics, Inc. |
4 |
A-Award |
--I |
503.0000 |
31559.0000 |
3 |
0001609351 |
Series B Preferred Stock |
D |
2015-02-04 |
|
Spark Therapeutics, Inc. |
4 |
C-Conversion |
--I |
31559.0000 |
0.0000 |
4 |
0001609351 |
Series B Preferred Stock |
A |
2014-02-28 |
|
Mead Johnson Nutrition Co |
4 |
A-Award |
--D |
2146.0000 |
2146.0000 |
6 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2014-02-27 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
1876.0000 |
7524.0000 |
1 |
0001452575 |
Common Stock |
D |
2014-02-27 |
|
Mead Johnson Nutrition Co |
4 |
M-Exempt |
--D |
1876.0000 |
0.0000 |
5 |
0001452575 |
Restricted Stock Unit (RSU) |
A |
2013-06-03 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
98875.0000 |
231868.0000 |
1 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-06-03 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
83647.0000 |
148221.0000 |
2 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-06-03 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
98875.0000 |
25000.0000 |
7 |
0000014272 |
Executive Option (right to buy) |
D |
2013-05-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
143521.0000 |
132993.0000 |
3 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-05-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
50000.0000 |
276514.0000 |
2 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-05-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
120625.0000 |
226514.0000 |
1 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-05-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
120625.0000 |
123875.0000 |
8 |
0000014272 |
Executive Option (right to buy) |
D |
2013-05-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
50000.0000 |
0.0000 |
9 |
0000014272 |
Executive Option (right to buy) |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
202405.0000 |
50000.0000 |
24 |
0000014272 |
Executive Option (right to buy) |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
103500.0000 |
0.0000 |
23 |
0000014272 |
Executive Option (right to buy) |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--I |
459.0000 |
9091.0000 |
18 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
202405.0000 |
355898.0000 |
8 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--I |
919.0000 |
18180.0000 |
16 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
103500.0000 |
459398.0000 |
9 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
88132.0000 |
371266.0000 |
10 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
90234.0000 |
281032.0000 |
11 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
175143.0000 |
105889.0000 |
12 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-30 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--I |
919.0000 |
18180.0000 |
14 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
9600.0000 |
248811.0000 |
4 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
11092.0000 |
258411.0000 |
3 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
21856.0000 |
226955.0000 |
5 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
25795.0000 |
247319.0000 |
2 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
36503.0000 |
221524.0000 |
1 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
31594.0000 |
195361.0000 |
6 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--D |
41868.0000 |
153493.0000 |
7 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--I |
18313.0000 |
19099.0000 |
13 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--I |
9157.0000 |
9550.0000 |
17 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
11092.0000 |
288908.0000 |
21 |
0000014272 |
Executive Option (right to buy) |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
25795.0000 |
0.0000 |
20 |
0000014272 |
Executive Option (right to buy) |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
S-Sale |
--I |
18313.0000 |
19099.0000 |
15 |
0000014272 |
Common Stock, $0.10 par value |
D |
2013-04-29 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
36503.0000 |
252405.0000 |
22 |
0000014272 |
Executive Option (right to buy) |
A |
2013-03-10 |
|
BRISTOL MYERS SQUIBB CO |
4 |
A-Award |
--D |
29630.0000 |
29630.0000 |
1 |
0000014272 |
Market Share Units |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
A-Award |
--D |
21166.0000 |
21166.0000 |
24 |
0000014272 |
Performance Shares |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
11715.0000 |
238930.0000 |
3 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
A-Award |
--D |
29007.0000 |
95979.9577 |
19 |
0000014272 |
Performance Shares |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
J-Other |
--D |
3832.0423 |
99812.0000 |
20 |
0000014272 |
Performance Shares |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
J-Other |
--D |
844.8480 |
22010.8480 |
25 |
0000014272 |
Performance Shares |
D |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
8801.0000 |
26406.0000 |
18 |
0000014272 |
Market Share Units |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
99812.0000 |
215153.0000 |
1 |
0000014272 |
Common Stock, $0.10 par value |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
A-Award |
--D |
27866.0000 |
61777.0000 |
22 |
0000014272 |
Performance Shares |
A |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
J-Other |
--D |
2465.8489 |
64242.8489 |
23 |
0000014272 |
Performance Shares |
D |
2013-03-07 |
|
BRISTOL MYERS SQUIBB CO |
4 |
M-Exempt |
--D |
99812.0000 |
0.0000 |
21 |
0000014272 |
Performance Shares |